Marksans-Pharma Stock/Share Prices, Buy and Sell Marksans-Pharma BSE Stocks

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

20 Apr 2018 | 03:59 PM

33.35

-0.80 (-2.34%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-37.55%

Return (1Y)

Underperformed S&P BSE Healthcare by 27.91%
More Volatile

2.77%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.71%
Not so consistent

4/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Marksans Pharma announces appointment of director
37 days ago

Marksans Pharma announces appointment of director

14 - Mar - 2018 12:00 AM | 37 days ago

Marksans Pharma has appointed Digant Mahesh Parikh as Independent Director at board meeting held on 14 March 2018.
Powered by Capital Market - Live News
Marksans Pharma consolidated net profit rises 68.37% in the December 2017 quarter
67 days ago

Marksans Pharma consolidated net profit rises 68.37% in the December 2017 quarter

12 - Feb - 2018 12:00 AM | 67 days ago

Net profit of Marksans Pharma rose 68.37% to Rs 16.77 crore in the quarter ended December 2017 as against Rs 9.96 crore during the previous quarter ended December 2016. Sales rose 1.48% to Rs 218.43 crore in the quarter ended December 2017 as against Rs 215.24 crore during the previous quarter ended December 2016.
Particulars Quarter Ended
Dec. 2017 Dec. 2016 % Var.
Sales 218.43 215.24 1
OPM % 13.21 12.45 -
PBDT 27.47 24.98 10
PBT 21.25 13.15 62
NP 16.77 9.96 68
Powered by Capital Market - Live News
Marksans Pharma standalone net profit declines 20.73% in the December 2017 quarter
67 days ago

Marksans Pharma standalone net profit declines 20.73% in the December 2017 quarter

12 - Feb - 2018 12:00 AM | 67 days ago

Net profit of Marksans Pharma declined 20.73% to Rs 5.62 crore in the quarter ended December 2017 as against Rs 7.09 crore during the previous quarter ended December 2016. Sales rose 23.92% to Rs 80.03 crore in the quarter ended December 2017 as against Rs 64.58 crore during the previous quarter ended December 2016.
Particulars Quarter Ended
Dec. 2017 Dec. 2016 % Var.
Sales 80.03 64.58 24
OPM % 14.38 21.04 -
PBDT 10.25 12.48 -18
PBT 7.66 8.72 -12
NP 5.62 7.09 -21
Powered by Capital Market - Live News
Marksans Pharma announces resignation of director
108 days ago

Marksans Pharma announces resignation of director

02 - Jan - 2018 12:00 AM | 108 days ago

Marksans Pharma announced that Naresh Balwant Wadhwa (DIN: 01999073), has resigned as a Director of the Company with effect from 2 January, 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has decreased by -33.16% since past 3 Months
FII shareholding in Marksans Pharma Ltd has decreased by -62.12% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2017	Dec. 2016	% Var.
Sales	218.43	215.24	1
OPM %	13.21	12.45	-
PBDT	27.47	24.98	10
PBT	21.25	13.15	62
NP	16.77	9.96	68

Particulars	Quarter Ended
	Dec. 2017	Dec. 2016	% Var.
Sales	80.03	64.58	24
OPM %	14.38	21.04	-
PBDT	10.25	12.48	-18
PBT	7.66	8.72	-12
NP	5.62	7.09	-21

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Mid Cap

33.35 -0.80 (-2.34%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

33.35

-0.80 (-2.34%)